Docoh
Loading...

BDTX Black Diamond Therapeutics

News

From Benzinga Pro
Stocks That Hit 52-Week Lows On Friday
14 Jan 22
News, Options, Intraday Update, Markets, Movers, Trading Ideas
During Friday's session, 445 companies made new 52-week lows.
Why Black Diamond Therapeutics Stock Is Trading Higher Today
11 Jan 22
News, FDA, Movers, Trading Ideas
Black Diamond Therapeutics Inc (NASDAQ: BDTX) is trading higher Tuesday after the company announced it received U.S.
The Daily Biotech Pulse: Illumina Announces Multiple Partnerships, Immunome Slides On Regulatory Setback For COVID Antibody Drug, Preannouncements Pour In
11 Jan 22
Biotech, News, Penny Stocks, Guidance, Small Cap, FDA, General
Here's a roundup of top developments in the biotech space over the last 24 hours:
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
11 Jan 22
Pre-Market Outlook, Markets, Movers
Black Diamond Therapeutics Announces FDA Allowance Of IND Application For BDTX-1535, A MasterKey Inhibitor Of EGFR for Treatment Of Gliobastoma And Non-Small Cell Lung Cancer
11 Jan 22
Biotech, News, FDA, General
Black Diamond Therapeutics, Inc. (NASDAQ:BDTX), a precision oncology medicine company pioneering the discovery and development of MasterKey therapies, today announced that the U.S. Food and Drug Administration (FDA) has
Stocks That Hit 52-Week Lows On Thursday
6 Jan 22
News, Options, Intraday Update, Markets, Movers, Trading Ideas
On Thursday, 615 stocks hit new 52-week lows.
12 Health Care Stocks Moving In Thursday's Pre-Market Session
9 Dec 21
Pre-Market Outlook, Markets, Movers
Black Diamond Therapeutic Q3 EPS $(0.97) Down From $(0.50) YoY
8 Nov 21
Earnings, News
Black Diamond Therapeutic (NASDAQ:BDTX) reported quarterly losses of $(0.97) per share. This is a 94 percent decrease over losses of $(0.50) per share from the same period last year.